Colleen McBride and colleagues argue that progress on a multifaceted research agenda is necessary to reap the full benefits and avoid the potential pitfalls of the emerging area of personalized ...
observations from the SCD-HeFT trial 9 on the primary prevention of sudden death indicate that we may need to reconsider this supposition. In the subgroup of patients with NYHA class III heart ...